More than 35 000 people die from antimicrobial-resistant infections in the EU/EEA each year, according to estimates presented in a new report released today. The estimated number of deaths in the report examines the years 2016-2020 and shows an increase from previous estimates. The health impact of antimicrobial resistance (AMR) is comparable to that of influenza, tuberculosis and HIV/AIDS combined.
Version 6.1 is the final protocol for the third EU-wide point prevalence survey in acute care hospitals (PPS 2022–2023). It contains important changes compared to protocol version 5.3 (PPS 2016–2017), including on healthcare-associated COVID-19.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 October 2022 and includes updates on avian influenza, COVID-19, dengue, Ebola, invasive meningococcal disease, West Nile Virus, MERS-CoV, monkeypox, and hepatitis.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 31 July-6 August and includes updates on West Nile virus infection, monkeypox, COVID-19, cholera, diphteria, anthrax, Vibrio growth, Marburg virus disease, mass gatherings at the Birmingham 2022 Commonwealth games, MERS-CoV, and Poliovirus.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 24 -30 July and includes updates on COVID-19, monkeypox, West Nile virus, increase in hepatitis of unknown aetiology in children, mass gatherings in the Birmingham 2022 Commonwealth games, Vibrio growth, Marburg disease, Chikungunya, dengue, and wild poliovirus.